ImageneBio annual depreciation and amortization
2020
2021
2022
2023
2024
2025
ImageneBio Depreciation & Amortization Growth & History (IMA)
ImageneBio's depreciation and amortization was $400,000 for fiscal 2025.
View full ImageneBio company overviewImageneBio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $400,000 | −$700,000 | −63.64% |
| 2024 | 2024-12-31 | $1.1M | $80,000 | +7.84% |
| 2023 | 2023-12-31 | $1.0M | $269,000 | +35.82% |
| 2022 | 2022-12-31 | $751,000 | $207,000 | +38.05% |
| 2021 | 2021-12-31 | $544,000 | $244,000 | +81.33% |
| 2020 | 2020-12-31 | $300,000 | — | — |
ImageneBio quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$2,000 | — |
| Q1 2026 | 2026-03-31 | $0 | −$2,000 | — |
| Q4 2025 | 2025-12-31 | $561,000 | — | — |
| Q3 2025 | 2025-09-30 | $2,000 | −$88,000 | −97.78% |
| Q2 2025 · Jun 30 | 2025-06-30 | $2,000 | −$90,000 | −97.83% |
| Q1 2025 | 2025-03-31 | $2,000 | −$217,000 | −99.09% |
| Q3 2024 | 2024-09-30 | $90,000 | −$152,000 | −62.81% |
| Q2 2024 | 2024-06-30 | $92,000 | −$150,000 | −61.98% |
| Q1 2024 | 2024-03-31 | $219,000 | −$12,000 | −5.19% |
| Q3 2023 | 2023-09-30 | $242,000 | $29,000 | +13.62% |
| Q2 2023 | 2023-06-30 | $242,000 | $94,000 | +63.51% |
| Q1 2023 | 2023-03-31 | $231,000 | $51,000 | +28.33% |
| Q3 2022 | 2022-09-30 | $213,000 | $113,000 | +113.00% |
| Q2 2022 | 2022-06-30 | $148,000 | $48,000 | +48.00% |
| Q1 2022 | 2022-03-31 | $180,000 | $91,000 | +102.25% |
| Q3 2021 | 2021-09-30 | $100,000 | $0 | 0.00% |
| Q2 2021 | 2021-06-30 | $100,000 | $0 | 0.00% |
| Q1 2021 | 2021-03-31 | $89,000 | $15,000 | +20.27% |
| Q3 2020 | 2020-09-30 | $100,000 | — | — |
| Q2 2020 | 2020-06-30 | $100,000 | — | — |
| Q1 2020 | 2020-03-31 | $74,000 | — | — |
ImageneBio depreciation and amortization trends
Over the last five fiscal years, ImageneBio's depreciation and amortization increased from $300,000 to $400,000, a change of $100,000. The latest reported quarter, Q2 2026, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ImageneBio source filings ↗